Cargando…
Infused Therapy and Survival in Older Patients Diagnosed with Metastatic Breast Cancer who Received Trastuzumab
We used Surveillance, Epidemiology, and End Results-Medicare data (2000-2006) to describe treatment and survival in women diagnosed with metastatic breast cancer (MBC) who received trastuzumab. There were 610 patients with a mean age of 74 years. Overall, 32% received trastuzumab alone and 47% recei...
Autores principales: | Griffiths, Robert I, Lalla, Deepa, Herbert, Robert J, Doan, Justin F, Brammer, Melissa G, Danese, Mark D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212922/ https://www.ncbi.nlm.nih.gov/pubmed/21929325 http://dx.doi.org/10.3109/07357907.2011.616251 |
Ejemplares similares
-
A Walnut-Enriched Diet Reduces the Growth of LNCaP Human Prostate Cancer Xenografts in Nude Mice
por: Reiter, Russel J., et al.
Publicado: (2013) -
Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer
por: Danese, Mark D., et al.
Publicado: (2012) -
Discussion: Causative Agent
por: Andiman, Warren A.
Publicado: (1984) -
Discussion: Vector and Causative Agent
por: Main, Andrew J.
Publicado: (1984) -
Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis
por: Guérin, Annie, et al.
Publicado: (2014)